RELARC&Co SRL
RELARC&Co reported total assets of 709,679 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of RELARC&Co shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets +60 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
RELARC&Co's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 27 Aug 2022
RELARC&Co's financial analysis
- Solvency22.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of RELARC&Co
RELARC&Co's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0678.738.890
- VAT number
- BE0678738890
- Peppol
- Registered · 0208:0678738890 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jul 2017
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
RELARC&Co (SRL) has been based in Ghent since 2017, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 64,795 € and equity of 160,546 €; its revenue is not published. Its solvency stands at 22.6%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to RELARC&Co
Companies in the same business, of comparable size and area, outside its group.
- Biotech Dental Benelux Wholesale of pharmaceutical and medical goods Ghent · balance sheet 778,336 €
- New Instruphar Wholesale of pharmaceutical and medical goods Ghent · balance sheet 599,845 €
- 2Pharma Wholesale of pharmaceutical and medical goods Ghent · balance sheet €1.12m
- Newclip Technics Belgium Wholesale of pharmaceutical and medical goods Jette · balance sheet 500,312 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
Frequently asked questions about RELARC&Co
What is the revenue of RELARC&Co?
RELARC&Co files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of RELARC&Co?
In Belgium, the VAT number is the company number prefixed with BE: BE0678738890 for RELARC&Co, if the company is VAT-registered. Its company number (CBE) is 0678.738.890.
Where is the registered office of RELARC&Co?
According to the CBE register, the registered office of RELARC&Co is in 9000 Ghent.
What is the equity of RELARC&Co?
At the close of the 2025 financial year, the equity of RELARC&Co amounts to 160,546 €, a solvency of 22.6% of total assets.
Who manages RELARC&Co?
The register lists 2 active mandates at RELARC&Co. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of RELARC&Co
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →